首页 > 最新文献

Journal of the American Academy of Child and Adolescent Psychiatry最新文献

英文 中文
Editorial: Neuroprotection Across Generations: Maternal Childhood Trauma and the Developing Amygdala 社论:跨代的神经保护:母亲童年创伤和发育中的杏仁核
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-06-12 DOI: 10.1016/j.jaac.2025.06.002
Giorgia Picci PhD
{"title":"Editorial: Neuroprotection Across Generations: Maternal Childhood Trauma and the Developing Amygdala","authors":"Giorgia Picci PhD","doi":"10.1016/j.jaac.2025.06.002","DOIUrl":"10.1016/j.jaac.2025.06.002","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 349-351"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144289865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Neurodevelopmental Outcomes of Prenatal Antipsychotic Medication Exposure 社论:产前抗精神病药物暴露的神经发育结果
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-08-20 DOI: 10.1016/j.jaac.2025.08.008
Janet Charoensook MD
{"title":"Editorial: Neurodevelopmental Outcomes of Prenatal Antipsychotic Medication Exposure","authors":"Janet Charoensook MD","doi":"10.1016/j.jaac.2025.08.008","DOIUrl":"10.1016/j.jaac.2025.08.008","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 340-342"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144898335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling Disparities: The Case for Group-Specific Analyses in Child Psychiatry 揭示差异:儿童精神病学群体特定分析的案例。
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-05-23 DOI: 10.1016/j.jaac.2025.05.009
Magdalena Janecka PhD , Candice Medina MS , Nina Zaks MS , Khaoula Ben Messaoud PhD , Vahe Khachadourian MD, MPH, PhD , Lisa A. Croen PhD
{"title":"Unveiling Disparities: The Case for Group-Specific Analyses in Child Psychiatry","authors":"Magdalena Janecka PhD , Candice Medina MS , Nina Zaks MS , Khaoula Ben Messaoud PhD , Vahe Khachadourian MD, MPH, PhD , Lisa A. Croen PhD","doi":"10.1016/j.jaac.2025.05.009","DOIUrl":"10.1016/j.jaac.2025.05.009","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 337-339"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144136660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Reframing Risk: Antidepressant Use in Pregnancy and Offspring Mental Health 社论:重新定义风险:抗抑郁药在怀孕和后代心理健康中的使用。
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-06-18 DOI: 10.1016/j.jaac.2025.06.008
Misty C. Richards MD, MS
{"title":"Editorial: Reframing Risk: Antidepressant Use in Pregnancy and Offspring Mental Health","authors":"Misty C. Richards MD, MS","doi":"10.1016/j.jaac.2025.06.008","DOIUrl":"10.1016/j.jaac.2025.06.008","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 346-348"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144335317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Cautious Optimism for Noninvasive Brain Stimulation in Attention-Deficit/Hyperactivity Disorder: What Does the Evidence Show? 社论:对非侵入性脑刺激治疗注意缺陷/多动障碍的谨慎乐观:证据显示了什么?
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-08-28 DOI: 10.1016/j.jaac.2025.08.018
Douglas Teixeira Leffa MD, PhD
{"title":"Editorial: Cautious Optimism for Noninvasive Brain Stimulation in Attention-Deficit/Hyperactivity Disorder: What Does the Evidence Show?","authors":"Douglas Teixeira Leffa MD, PhD","doi":"10.1016/j.jaac.2025.08.018","DOIUrl":"10.1016/j.jaac.2025.08.018","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 343-345"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144958746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital Playlist 医院播放列表
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-11-06 DOI: 10.1016/j.jaac.2025.10.015
Dae Sun Hwang BA
{"title":"Hospital Playlist","authors":"Dae Sun Hwang BA","doi":"10.1016/j.jaac.2025.10.015","DOIUrl":"10.1016/j.jaac.2025.10.015","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 456-457"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145447441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Everything I Never Told You 我从未告诉你的一切
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-10-30 DOI: 10.1016/j.jaac.2025.10.014
Tyler C. Kung BA , Anna Hong BSA
{"title":"Everything I Never Told You","authors":"Tyler C. Kung BA , Anna Hong BSA","doi":"10.1016/j.jaac.2025.10.014","DOIUrl":"10.1016/j.jaac.2025.10.014","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 457-458"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145397128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal Antidepressant Exposure and Risk of Depression and Anxiety Disorders: An Electronic Health Records–Based Cohort Study 产前抗抑郁药物暴露与抑郁和焦虑症风险:一项基于电子健康记录的队列研究
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-04-07 DOI: 10.1016/j.jaac.2025.03.026
Ardesheer Talati PhD , Jennifer L. Vande Voort MD , Launia J. White BS , David Hodge MS , Cynthia J. Stoppel BS , Myrna M. Weissman PhD , Jay A. Gingrich MD, PhD , William V. Bobo MD, MPH

Objective

To examine the associations of serotonergic antidepressant exposure during pregnancy with the risk of depression and anxiety disorders in offspring.

Method

The Mayo Clinic Rochester Epidemiology Project medical records-linkage system was used to study offspring born to mothers who were prescribed a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor (S/NRI users, n = 837) during pregnancy (1997-2010). Cox regression models were used to calculate hazard ratios to examine associations of S/NRIs with diagnosed depression and anxiety, defined based on a review of medical records by 2 board-certified psychiatrists, vs no maternal antidepressant use during pregnancy (nonusers, n = 863) and maternal antidepressant use in the year prior to pregnancy (former users, n = 399) as control groups.

Results

After all adjustments for covariates, children born to S/NRI users during pregnancy did not differ in onset of depression or anxiety from the children of nonusers (adjusted hazard ratio = 1.00, 95% CI [0.74, 1.85]) or former users (adjusted hazard ratio = 0.94, 95% CI [0.69, 1.27]). These associations were similar when exposure was limited only to selective serotonin reuptake inhibitors.

Conclusion

The results suggest that higher rates of childhood and adolescent depression or anxiety conditioned on maternal S/NRI use in pregnancy are more likely to be driven by maternal depression or underlying propensity for depression rather than direct pharmacological effects of in utero S/NRI exposure.

Plain language summary

The authors examined the association between exposure to serotonergic antidepressants during pregnancy and risk of having depression and anxiety in their offspring using data regarding 2,099 participants in the Mayo Clinic Rochester Epidemiology Project. After accounting for maternal depression, prenatal serotonergic antidepressant exposure was not associated with higher risk for these outcomes compared to either unexposed children or those whose mothers used antidepressants prior to but not during pregnancy. Findings suggest that increased depression and anxiety observed in prenatally exposed children is more likely to be driven by maternal depression or underlying factors rather than the direct effects of pharmacological exposure to serotonin-based antidepressant medication.
目的探讨妊娠期5 -羟色胺类抗抑郁药暴露与后代抑郁和焦虑障碍风险的关系。方法采用梅奥诊所罗切斯特流行病学项目病历链接系统,对1997-2010年期间服用选择性血清素再摄取抑制剂或血清素-去甲肾上腺素再摄取抑制剂的母亲(S/NRI服药者,n=837)所生的后代进行研究。使用Cox回归模型计算风险比(hr)来检查S/NRIs与诊断出的抑郁和焦虑之间的关联,这些关联是基于两位委员会认证的精神科医生对医疗记录的回顾而定义的,使用孕期未使用抗抑郁药(非使用,n=863)和孕期前一年使用抗抑郁药(前使用,n=399)作为对照组。结果在所有协变量调整后,S/NRI使用者在怀孕期间所生的孩子与非使用者所生的孩子在抑郁或焦虑的发病方面没有差异(调整风险比(aHR [95% CI]=1.00[0.74, 1.85])或以前的使用者(aHR=0.94[0.69, 1.27])。当仅暴露于ssri类药物时,上述关联相似。结论:母亲妊娠期使用S/NRI导致的儿童和青少年抑郁或焦虑发生率较高,更可能是由母亲抑郁或潜在抑郁倾向驱动的,而不是子宫内S/NRI暴露的直接药理作用。
{"title":"Prenatal Antidepressant Exposure and Risk of Depression and Anxiety Disorders: An Electronic Health Records–Based Cohort Study","authors":"Ardesheer Talati PhD ,&nbsp;Jennifer L. Vande Voort MD ,&nbsp;Launia J. White BS ,&nbsp;David Hodge MS ,&nbsp;Cynthia J. Stoppel BS ,&nbsp;Myrna M. Weissman PhD ,&nbsp;Jay A. Gingrich MD, PhD ,&nbsp;William V. Bobo MD, MPH","doi":"10.1016/j.jaac.2025.03.026","DOIUrl":"10.1016/j.jaac.2025.03.026","url":null,"abstract":"<div><h3>Objective</h3><div>To examine the associations of serotonergic antidepressant exposure during pregnancy with the risk of depression and anxiety disorders in offspring.</div></div><div><h3>Method</h3><div><span><span>The Mayo Clinic Rochester Epidemiology Project medical records-linkage system was used to study offspring born to mothers who were prescribed a </span>selective serotonin reuptake inhibitor<span> or serotonin-norepinephrine reuptake inhibitor (S/NRI users, n = 837) during pregnancy (1997-2010). Cox regression models were used to calculate hazard ratios to examine associations of S/NRIs with diagnosed depression and anxiety, defined based on a review of </span></span>medical records by 2 board-certified psychiatrists, vs no maternal antidepressant use during pregnancy (nonusers, n = 863) and maternal antidepressant use in the year prior to pregnancy (former users, n = 399) as control groups.</div></div><div><h3>Results</h3><div>After all adjustments for covariates, children born to S/NRI users during pregnancy did not differ in onset of depression or anxiety from the children of nonusers (adjusted hazard ratio = 1.00, 95% CI [0.74, 1.85]) or former users (adjusted hazard ratio = 0.94, 95% CI [0.69, 1.27]). These associations were similar when exposure was limited only to selective serotonin reuptake inhibitors.</div></div><div><h3>Conclusion</h3><div>The results suggest that higher rates of childhood and adolescent depression or anxiety conditioned on maternal S/NRI use in pregnancy are more likely to be driven by maternal depression or underlying propensity for depression rather than direct pharmacological effects of in utero S/NRI exposure.</div></div><div><h3>Plain language summary</h3><div>The authors examined the association between exposure to serotonergic antidepressants during pregnancy and risk of having depression and anxiety in their offspring using data regarding 2,099 participants in the Mayo Clinic Rochester Epidemiology Project. After accounting for maternal depression, prenatal serotonergic antidepressant exposure was not associated with higher risk for these outcomes compared to either unexposed children or those whose mothers used antidepressants prior to but not during pregnancy. Findings suggest that increased depression and anxiety observed in prenatally exposed children is more likely to be driven by maternal depression or underlying factors rather than the direct effects of pharmacological exposure to serotonin-based antidepressant medication.</div></div>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 408-419"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143819290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Review: Antipsychotic Medication in Pregnancy and Neurodevelopmental Outcomes in Children 系统评价:妊娠期抗精神病药物治疗与儿童神经发育结局。
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-04-23 DOI: 10.1016/j.jaac.2025.04.008
Carly A. Kaplan BS , Eline M.P. Poels MD, PhD , Marion I. van den Heuvel PhD , Hilmar H. Bijma MD, PhD , Veerle Bergink MD, PhD , Anna-Sophie Rommel PhD , Thalia Robakis MD, PhD
<div><h3>Objective</h3><div>Antipsychotic medications are widely prescribed, including during pregnancy, and pregnant individuals worry about the potential sequelae for the child. Although antipsychotics do not seem to be teratogenic, the long-term neurodevelopmental impact of prenatal exposure remains unclear. A systematic review was conducted to determine if intrauterine antipsychotic exposure increases the risk of adverse neurodevelopmental outcomes.</div></div><div><h3>Method</h3><div>A systematic search was performed in MEDLINE, Cochrane, Embase, and PsycINFO for studies published before September 7, 2024. We included original studies assessing cognitive, motor, behavioral, social, and psychiatric outcomes in children prenatally exposed to antipsychotics, excluding case reports, reviews, preclinical studies, and studies without a control group. Quality and risk of bias were assessed using the Newcastle-Ottawa Scale.</div></div><div><h3>Results</h3><div>Of 1,349 studies identified, full text of 56 was screened, and 16 were included in the review. The number of exposed participants ranged from 11 to >15,000. In the 8 studies assessing motor development, early motor delays were observed but did not persist into later childhood. Neurodevelopmental disorders were assessed in 7 studies. Crude estimates showed greater risk in exposed children, but after adjusting for confounders, most studies found no significant risk. The mean NOS score was 7.1.</div></div><div><h3>Conclusion</h3><div>Transient motor delays may be associated with antipsychotic use during pregnancy, although future studies adjusting for confounding factors should clarify this risk. After adjustment for confounders, the risk of neurodevelopmental disorders in school-age children does not seem to be increased. Studies with longer follow-up time are required to further investigate the risk of neurodevelopmental disorders.</div></div><div><h3>Plain language summary</h3><div>This systematic review of research examines the mental, behavioral, and cognitive health outcomes of children whose mothers took antipsychotics during pregnancy. Sixteen articles were included in the review; the number of exposed participants in each study ranged from 11 to >15,000. The authors found that the majority of studies, especially those with longer-term follow-up and larger samples, did not identify increased neurodevelopmental problems in children who were exposed to antipsychotics during pregnancy. Some studies noted transient motor delays in exposed infants, but the authors found that they did not sufficiently account for the potential influence of severe maternal mental illness on this association.</div></div><div><h3>Clinical guidance</h3><div>• Antipsychotic use during pregnancy may be indicated for effective treatment of severe mental illness in pregnant women.</div><div>• A discussion that involves the risks of untreated maternal mental illness alongside existing data on antipsychotic exposur
目的抗精神病药物被广泛使用,包括在怀孕期间,孕妇担心给孩子带来潜在的后遗症。虽然抗精神病药物似乎没有致畸性,但产前暴露对神经发育的长期影响仍不清楚。进行了一项系统评价,以确定宫内抗精神病药物暴露是否会增加不良神经发育结果的风险。方法系统检索MEDLINE、Cochrane、Embase和PsycINFO数据库中2024年9月7日前发表的研究。我们纳入了评估产前暴露于抗精神病药物的儿童的认知、运动、行为、社会和精神结局的原始研究,排除了病例报告、综述、临床前研究和没有对照组的研究。使用纽卡斯尔-渥太华量表(NOS)评估偏倚的质量和风险。结果在1349项研究中,56项进行了全文筛选,16项纳入了本综述。受影响的参与者人数从11人到1.5万人不等。在八项评估运动发育的研究中,观察到早期运动迟缓,但没有持续到儿童后期。在7项研究中评估了神经发育障碍。粗略的估计显示,暴露在环境中的儿童的风险更大,但在调整了混杂因素后,大多数研究发现没有显著的风险。NOS平均评分为7.1分。结论:短暂性运动迟缓可能与妊娠期间使用抗精神病药物有关,尽管未来的研究调整了混杂因素,应阐明这一风险。在对混杂因素进行调整后,学龄儿童神经发育障碍的风险似乎并没有增加。需要更长的随访时间来进一步调查神经发育障碍的风险。研究资料:产前抗精神病药物暴露对神经发育的影响:系统回顾和荟萃分析https://www.crd.york.ac.uk/PROSPERO/view/CRD42024499352。
{"title":"Systematic Review: Antipsychotic Medication in Pregnancy and Neurodevelopmental Outcomes in Children","authors":"Carly A. Kaplan BS ,&nbsp;Eline M.P. Poels MD, PhD ,&nbsp;Marion I. van den Heuvel PhD ,&nbsp;Hilmar H. Bijma MD, PhD ,&nbsp;Veerle Bergink MD, PhD ,&nbsp;Anna-Sophie Rommel PhD ,&nbsp;Thalia Robakis MD, PhD","doi":"10.1016/j.jaac.2025.04.008","DOIUrl":"10.1016/j.jaac.2025.04.008","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;Antipsychotic medications are widely prescribed, including during pregnancy, and pregnant individuals worry about the potential sequelae for the child. Although antipsychotics do not seem to be teratogenic, the long-term neurodevelopmental impact of prenatal exposure remains unclear. A systematic review was conducted to determine if intrauterine antipsychotic exposure increases the risk of adverse neurodevelopmental outcomes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Method&lt;/h3&gt;&lt;div&gt;A systematic search was performed in MEDLINE, Cochrane, Embase, and PsycINFO for studies published before September 7, 2024. We included original studies assessing cognitive, motor, behavioral, social, and psychiatric outcomes in children prenatally exposed to antipsychotics, excluding case reports, reviews, preclinical studies, and studies without a control group. Quality and risk of bias were assessed using the Newcastle-Ottawa Scale.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Of 1,349 studies identified, full text of 56 was screened, and 16 were included in the review. The number of exposed participants ranged from 11 to &gt;15,000. In the 8 studies assessing motor development, early motor delays were observed but did not persist into later childhood. Neurodevelopmental disorders were assessed in 7 studies. Crude estimates showed greater risk in exposed children, but after adjusting for confounders, most studies found no significant risk. The mean NOS score was 7.1.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Transient motor delays may be associated with antipsychotic use during pregnancy, although future studies adjusting for confounding factors should clarify this risk. After adjustment for confounders, the risk of neurodevelopmental disorders in school-age children does not seem to be increased. Studies with longer follow-up time are required to further investigate the risk of neurodevelopmental disorders.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Plain language summary&lt;/h3&gt;&lt;div&gt;This systematic review of research examines the mental, behavioral, and cognitive health outcomes of children whose mothers took antipsychotics during pregnancy. Sixteen articles were included in the review; the number of exposed participants in each study ranged from 11 to &gt;15,000. The authors found that the majority of studies, especially those with longer-term follow-up and larger samples, did not identify increased neurodevelopmental problems in children who were exposed to antipsychotics during pregnancy. Some studies noted transient motor delays in exposed infants, but the authors found that they did not sufficiently account for the potential influence of severe maternal mental illness on this association.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Clinical guidance&lt;/h3&gt;&lt;div&gt;• Antipsychotic use during pregnancy may be indicated for effective treatment of severe mental illness in pregnant women.&lt;/div&gt;&lt;div&gt;• A discussion that involves the risks of untreated maternal mental illness alongside existing data on antipsychotic exposur","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 354-368"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143876431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reevaluating Suicide Risk Screening in Preadolescents: Beyond Safety Toward Strategic Integration 重新评估青少年前自杀风险筛查:从安全走向战略整合。
IF 9.5 1区 医学 Q1 PEDIATRICS Pub Date : 2026-03-01 Epub Date: 2025-08-14 DOI: 10.1016/j.jaac.2025.08.003
Zhenzhuang Zou MD , Jiaying Liu MD , Li Fu MD , Bo Huang MD , Shaohua Wang MD
{"title":"Reevaluating Suicide Risk Screening in Preadolescents: Beyond Safety Toward Strategic Integration","authors":"Zhenzhuang Zou MD ,&nbsp;Jiaying Liu MD ,&nbsp;Li Fu MD ,&nbsp;Bo Huang MD ,&nbsp;Shaohua Wang MD","doi":"10.1016/j.jaac.2025.08.003","DOIUrl":"10.1016/j.jaac.2025.08.003","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":"65 3","pages":"Pages 327-328"},"PeriodicalIF":9.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144860123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the American Academy of Child and Adolescent Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1